Evidence map›Paper›PMID 18596849›Full record

ArticleTransactions of the American Clinical and Climatological Association2008

Pulmonary endothelial cell signaling and function.

Sharon Rounds, Qing Lu, Elizabeth O Harrington, Julie Newton, Brian Casserly

Open access · greenAbstract read
In one paragraph

Article in Transactions of the American Clinical and Climatological Association, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The effect of ultrasound cavitation on endothelial cells.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  5. Regulation of pulmonary endothelial barrier function by kinases.American journal of physiology. Lung cellular and molecular physiology · 2016
    Review
  6. Control of RhoA methylation by carboxylesterase I.The Journal of biological chemistry · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sharon RoundsVascular Research Laboratory, Department of Medicine, Warren Alpert Medical School of Brown University, Providence VA Medical Center, Providence, Rhode Island 02903, USA. sharon_rounds@brown.edu
Qing Lu
Elizabeth O Harrington
Julie Newton
Brian Casserly
Providence VA Medical Center · US

Funding

Endothelial Barrier Function Modulation by PKCDeltaR01HL067795 · NHLBI · BROWN UNIVERSITY · PI HARRINGTON, ELIZABETH O · 2001 to 2011
$3.0M
Small GTPases and Lung Endothelial ApoptosisR01HL064936 · NHLBI · BROWN UNIVERSITY · PI ROUNDS, SHARON IRENE SMITH · 2000 to 2009
$2.5M
NHLBI NIH HHS HL 64936NHLBI NIH HHS HL 67795NHLBI NIH HHS R01 HL064936NHLBI NIH HHS R01 HL067795
6 · The paper itself

Abstract

RhoA is an important modulator of endothelial monolayer permeability. Posttranslational carboxyl methylation of small GTPases, such as RhoA and Ras, regulates subcellular localization and GTPase activity, resulting in altered cellular function. In this study, we investigated the role of RhoA carboxyl methylation in modulating endothelial monolayer permeability. We found that inhibition of isoprenylcysteine-O-carboxyl methyltransferase (ICMT) with adenosine plus homocysteine (Ado/HC) or N-acetyl-S-geranylgeranyl-L-cysteine (AGGC) decreased RhoA carboxyl methylation and activation, which correlated with decreased monolayer permeability of bovine pulmonary artery endothelial cells (BPAEC). Conversely, BPAEC stably overexpressing ICMT had enhanced endothelial monolayer permeability, associated with elevated RhoA carboxyl methylation and activation. These results suggest that ICMT modulates endothelial monolayer permeability by altering RhoA carboxyl methylation and activation. In addition, we demonstrated that adenosine deaminase inhibitor not only attenuated, but also rescued, lung edema induced by a non-inflammatory edemagenic agent. Our data suggest that increasing intracellular adenosine is a useful therapeutic strategy against diseases characterized by increased vascular permeability.

Indexed as

Adenosine Deaminase InhibitorsAnimalsCapillary PermeabilityCattleCell LineEndothelial CellsEnzyme InhibitorsMiceMice, Inbred C57BLModels, BiologicalProtein MethyltransferasesProtein Processing, Post-TranslationalPulmonary ArteryRecombinant ProteinsrhoA GTP-Binding ProteinSignal TransductionAdenosine Deaminase Inhibitorsalpha-naphthyl thioureaEnzyme InhibitorsProtein Methyltransferasesprotein-S-isoprenylcysteine O-methyltransferaseRecombinant ProteinsrhoA GTP-Binding ProteinThioureaadenosinecarboxyl methylationedemaendothelial monolayer permeabilityRhoA

Identifiers

PMID18596849
PMCPMC2394687
OpenAlexW11298052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.